Suppr超能文献

将三种尿路上皮癌的发病风险与肥胖和超重联系起来:系统评价证据图谱概述。

Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews.

机构信息

Evidence-Based Nursing Centre, School of Nursing, Lanzhou University, Lanzhou City, 730000, China.

Evidence-Based Medicine Centre, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, 730000, China.

出版信息

Syst Rev. 2021 Feb 17;10(1):58. doi: 10.1186/s13643-021-01606-8.

Abstract

BACKGROUND

The relationship between cancer with overweight and obesity has been extensively reported. However, the association between urinary cancers with these risk factors remains unclear, with existing reports showing conflicting findings. The current review, therefore, sought to clarify the latter association by assessing the methodological and reporting quality of existing systematic reviews on the subject.

METHODS

We first screened PubMed, EMBASE, and Cochrane Library databases for relevant literature and subjected the resulting articles to meta-analysis. We adopted the AMSTAR-2 and PRISMA checklists for assessing methodological and reporting quality, respectively, then performed meta-analyses to determine the relationship between incidence and mortality of three types of urinary cancers with obesity and overweight. Indirect comparisons were also done across subgroups.

RESULTS

All systematic reviews (SRs) were of critically low methodological quality. Seventeen SRs had minimal reporting flaws, and 11 SRs had minor reporting flaws. We found an association between obesity with an incidence of kidney (RR = 1.68, 95% CI 1.47-1.92), bladder (RR = 1.1, 95% CI 1.07-1.13), and prostate (RR = 1.02, 95% CI 0.91, 1.13) cancers. Similarly, overweight was associated with the incidence of the three types of cancer, recording RR values of 1.37 (95% CI 1.26-1.48), 1.07 (95% CI 1.03-1.1), and 1 (95% CI 0.93, 1.07) for kidney, bladder, and prostate cancers, respectively. With regard to the dose analysis, the RR of BMI (per 5 kg/m increase) was associated with kidney (RR = 1.24, 95% CI 1.2-1.28), bladder (RR = 1.03, 95% CI 1.02-1.05), and prostate (RR = 1.02, 95% CI 1.01, 1.03) cancers.

CONCLUSIONS

This comprehensive quantitative analysis provides an affirmation that overweight and obesity are strong risk factors for kidney cancer, owing to a strong association between them. Conversely, a weak association between overweight and obesity with bladder and prostate cancers confirms their status as mild risk factors for the 2 types of cancer. But due to the low quality of included SRs, the results need to be interpreted with caution.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO CRD42019119459.

摘要

背景

超重和肥胖与癌症之间的关系已被广泛报道。然而,尿路癌与这些危险因素之间的关联尚不清楚,现有报告的结果存在矛盾。因此,本综述旨在通过评估有关该主题的系统评价的方法学和报告质量来阐明后者的关联。

方法

我们首先筛选了 PubMed、EMBASE 和 Cochrane 图书馆数据库中的相关文献,并对得到的文章进行了荟萃分析。我们分别采用 AMSTAR-2 和 PRISMA 清单评估方法学和报告质量,然后进行荟萃分析以确定肥胖和超重与三种类型的尿路癌的发病率和死亡率之间的关系。还进行了亚组间的间接比较。

结果

所有系统评价(SRs)的方法学质量均极低。有 17 项 SR 仅有轻微的报告缺陷,有 11 项 SR 有较小的报告缺陷。我们发现肥胖与肾癌(RR=1.68,95%CI 1.47-1.92)、膀胱癌(RR=1.1,95%CI 1.07-1.13)和前列腺癌(RR=1.02,95%CI 0.91,1.13)的发病率之间存在关联。同样,超重与三种类型的癌症的发病率有关,分别记录了 RR 值为 1.37(95%CI 1.26-1.48)、1.07(95%CI 1.03-1.1)和 1(95%CI 0.93,1.07)对于肾癌、膀胱癌和前列腺癌。关于剂量分析,BMI(每增加 5kg/m)与肾癌(RR=1.24,95%CI 1.2-1.28)、膀胱癌(RR=1.03,95%CI 1.02-1.05)和前列腺癌(RR=1.02,95%CI 1.01,1.03)有关。

结论

这项全面的定量分析证实,超重和肥胖是肾癌的强烈危险因素,因为它们之间存在很强的关联。相反,超重和肥胖与膀胱癌和前列腺癌之间的关联较弱,证实了它们是这两种癌症的轻度危险因素。但是,由于包括的 SR 质量较低,因此需要谨慎解释结果。

系统评价注册

PROSPERO CRD42019119459。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7888186/d9381db8d062/13643_2021_1606_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验